Trump Signs Executive Orders at White House (April 18)

Live News Network
1.4K followers
607 Video Views·Apr 18, 2026
President Donald Trump signs executive orders at the White House at 9 a.m. ET on April 18.
I said, when is the news conference?
He said, Saturday morning.
I said, I don't know.
Has that ever happened to you?
Well, it's an honor.
And it's very important what we're doing.
So, as you see, and you know a lot of the people behind me there,
tremendous professionals, medical professionals most,
and some military, like Marcus, some great military professionals too.
Real hero.
Today, I'm pleased to announce historic reforms to dramatically
accelerate access to new medical research and treatments
based on psychedelic drugs.
In many cases, these experimental treatments have shown
life-changing potential for those suffering from severe mental illness
and depression, including our cherished veterans.
Our veterans are having a tremendous hard time.
You know, the suicide rate, we have it down a little bit,
but they are having a hard time.
And I got a call from a number of people, including the great Joe Rogan.
And he said, we have to do something about this.
And I looked into it.
I called Bobby.
I called Oz.
I called Marty and Jay.
And it was really, it was uniform support.
And I said, so why would we wait three or four years to get it done?
Or 10 years, frankly.
Let's get it done immediately.
And that's what happened.
This has probably never been anything happened so quickly.
Everybody is so strongly in favor of this.
It's for a lot of people, but it's for our military in particular.
The suicide epidemic among veterans is a national tragedy.
Since 9-11, we've lost over 21 times more veteran lives to suicide
than on the battlefield.
So we lose, think of that, 21 times more.
And today we're bringing them new hope.
I think you're going to see a big difference and a big reduction in that number.
I want to thank Secretary of Health and Human Services, Robert F. Kennedy, Jr.,
who's a fantastic, where are you, Bobby?
Over here.
He always makes it difficult.
He's done a great job, too.
And people love him.
And more importantly, your wife is here someplace, Bobby.
She's out there.
Where are you?
The real boss in the family.
It's fantastic.
Thank you very much for being here, as well as FDA Commissioner Marnie McCary,
CMS Administrator Dr. Mehmet Oz, NIH Director Dr. Jay Bhattacharya.
See how easy that name is now?
It used to give me a little trouble.
That was a tough name.
Congressman Morgan Luttrell is a friend of mine and a real, he's a real war hero.
He knows something that a lot of us will never find out about.
Retired U.S. Navy SEAL Marcus Luttrell, the two of them.
I don't know what was in the, what's in your blood, fellas?
You guys, you guys.
Good mom and dad.
My mom and dad.
Good somebody.
Good to have you.
Joe Rogan is a fantastic person.
We did a little interview before the election.
We had over 300 million people.
And I said, oh, man, I hope Kamala doesn't do it.
And she didn't.
He wanted her to do it, but she didn't.
Someday Joe's going to explain why.
I could tell you why.
But along with many other, because she didn't want to.
With many other veterans.
And I just want to thank the people behind me are outstanding.
It's an amazing group.
The executive order I'm signing, we're actually signing the executive order today,
is really a moment.
It directs the FDA to expedite their review of certain psychedelics,
already designated as breakthrough therapy drugs.
They're very much being discussed.
It's one of the hottest things I think you're talking about, Oz, right?
It's nothing.
If these turn out to be as good as people are saying,
it's going to have a tremendous impact on this country and other countries too.
These treatments are currently in the advanced stages of clinical trials
to ensure that they're both safe and effective for the American patients.
And the nice part is we're actually doing this early, but it has been going on.
Research has been going on for quite some time.
But, you know, usually with things like this, nothing ever happens,
no matter how the research ends up.
But we're changing that.
This order will clear away unnecessary bureaucratic hurdles,
improve data sharing among the FDA and the Department of Veterans Affairs,
and facilitate fast rescheduling of any psychedelic drugs that become FDA approved.
And we think many of them will go very quickly.
And I have to say the most favored nations pricing that we established,
that I established, has been knocking the cost of drugs down by 50, 60, 70, 80 percent.
And, Oz, I want to thank you and Bobby for the great job you've done.
It's incredible.
The press refuses to write about it.
I think it's probably as big as what we're talking about today.
The drug costs are going down.
And, by the way, Trump Rx, which is where you go to get your very low-cost drugs.
But when you think, in my first term, for 28 years, drug prices went up,
and I got it down one quarter or one eighth of a percent.
I was so proud of myself.
It's the only one that, in 28 years, got them down.
And I had a news conference to explain how great I was.
I said, I'm the greatest there ever was.
I got it down one eighth of a percent.
Okay?
I was very proud because it only went up.
For 28 years, it went up.
Now I got it down a little bit.
And now I got it down 50 percent, 60 percent, 70 percent with these guys.
So now I am, you know.
But nobody wants to write about it.
But it doesn't matter because the people have found out,
you know, we're the highest we were, the highest in the world by far.
Sometimes we'd be 10 times higher than other countries.
You'd buy a drug.
I call it the fat pill or the fat drug.
You'd buy it in London.
You'd buy it for $10 for a pill, let's say, or a pill generally.
But actually, to be specific, London, $87.
New York, $1,300.
I said, how can that be possible?
How can it be possible?
$87.
And actually, a friend of mine called me up, and he said, you know,
he's a very rich guy, and he happens to be on this
Zepic, I guess, at the time.
And it was not working, by the way.
The guy was extremely successful but highly neurotic,
had a lot of problems.
I will not mention his name.
He's begging me not to mention it because he's become quite famous.
He's a big factor here.
But he's very smart, very rich guy, very, very successful guy.
And he said, hey, President.
He used to call me Donnie.
Now he calls me President.
It's out of respect.
He said, I'm in London.
I bought this stuff for $87.
In New York, I pay $1,300.
What's going on?
I said, well, that's the way it is.
We pay the highest prices in the world.
And it sort of hit me that how ridiculous it is.
Made, by the way.
He checked it.
He had a whole big research done on it because he couldn't believe it.
Made in the same factory, same plant, same.
Everything was the same except the price.
And now we are the lowest price.
We are tied.
In other words, whatever the lowest price in the world is,
that's the price we pay.
That's a tremendous difference.
So we'll be paying.
They go up a little bit.
So the $87 will go, like, to $120.
And we'll go down from $1,300 to $120.
So we'll have these massive price cuts.
And they've already started.
And I think it's one of the biggest things.
But unfortunately, the press doesn't like to talk about it.
Because if I were a Democrat, it would be headlines all over the place.
So I do that.
That's why I like live television, actually.
It's great because you can't do any cutting.
But we're so honored by that.
And that's going to have a huge impact on this also.
Because the pricing, not only is it important, but the pricing is going good.
And you're going to get the rescheduling done, right, please?
Will you get the rescheduling done, please?
You know they're slow-walking man's rescheduling.
Okay?
You're going to get it done, right?
In 2024 study from Stanford University, 30 special operation veterans
with traumatic brain injuries underwent what's called ibogaine treatment.
Ibogaine.
Remember the name.
Is that pronounced relatively properly, what you said?
Yes, sir.
I don't want to get it wrong.
Ibogaine because it's so important.
And experienced an 80% to 90% reduction in symptoms of depression
and anxiety within one month.
Can I have some, please?
I'll take it.
I'll take whatever it takes.
I don't have time to be depressed.
You know, if you stay busy enough, maybe that works too.
That's what I do.
In Texas, Republican leaders have already committed $50 million
to the ibogaine research, and today the federal government
is making a $50 million research investment in its own,
and so that was just approved just last night.
We're also opening a pathway for ibogaine to be administered
to desperately ill patients under the Right to Try law.
That's a law that I started, and I got Right to Try.
I'm very proud of that.
That was done in my first term, and I used to marvel at the fact
that people that were terminally ill could not get a drug.
They're terminally ill.
They're going to die.
And the FDA, right, Marty?
That's right.
Jay?
The FDA was protecting them from dying, but they're going to die.
And so we have these incredible drugs, and they may work
and they may not work, but we wouldn't let anybody get them
because they were bad for your health, but these are people
that were going to die.
And it never made sense to me.
So one of the first things I did early in my term,
and it was very tough to get, actually.
Hard to believe.
It was very tough with Congress, but they came through.
The Republicans came through.
And we have something called Right to Try,
and we've saved thousands and thousands of lives.
That's if you're terminally ill or very ill,
and there is a new drug that is not available
because it's going through the process of the FDA,
and Marty's cut that process down by 50 percent.
We're down.
It used to take 12 years, and now we have it down
to five or six years, and it's one of the most important things
that you can do.
But if you're terminally ill and there's a new drug
that may work or may not work, but it hasn't been approved yet,
you sign a document, and you're not going to hold
the country liable, you're not going to hold
the drug companies or the insurance companies
or anybody liable, and you have the right to try.
And what it's done, and nobody wanted it.
The insurance companies hated it.
Even the doctors, they were all afraid of it
because they didn't want to be sued.
But I took all of the liability out of it.
You sign a document, you're not going to sue the doctor,
you're not going to sue the hospital,
you're not going to sue anybody, including the country.
And everybody signs it, like, immediately.
And we have tens of thousands of people on this,
and we've saved thousands and thousands of lives.
And what it has done, we never thought of it so much as,
but what it has done is, in some cases,
these drugs are working so good.
It literally cures people that were terminally ill.
But it's one of the things I'm most proud of.
I'm proud of a lot of things we've done,
but that's one of the things we're most proud of.
Right to try.
But I've always believed in ensuring that
the American patients have access to breakthrough treatments
and therapies with love for our veterans.
And I have real love for our veterans.
I was with a group yesterday.
It's incredible what they've gone through.
And care for American patients.
Today's order will ensure that people
suffering from debilitating symptoms
might finally have a chance to reclaim their lives
and lead a happier life.
Just lead a happier life.
They've been through so much.
So I'd like to ask Secretary Kennedy to say a few words,
followed by Commissioner McCary, Marcus Luttrell, Joe Rogan,
and anybody in the group that would like to speak.
You're tremendous people.
I know many of you.
And you're really highly respected people.
And the Luttrell family is well represented.
But I don't mind having both Luttrells.
Both Luttrells can say a few words, okay?
Great people.
And so, Bobby, do you want to start it off, please?
Thank you, Mr. President.
Thank you very much.
Good morning, and thanks to the leadership of President Trump
for making this historic day possible.
Under the executive order,
HHS will accelerate research, approval,
and access to new mental health treatments,
including psychedelic therapies such as Ibogaine.
We're taking this decision, this decisive step,
to confront one of the most urgent public health challenges
facing our nation, the mental health crisis.
More than 14 million Americans live with serious mental illness,
and one in four adults experiences a diagnosable disorder each year.
Suicide has risen by more than 30% over the past two decades,
with another peak in recent years.
Among veterans, more than 6,000 die by suicide each year since 2001.
We have lost far more veterans to suicide than to combat.
At the same time, millions of Americans living with depression, PTSD, addiction,
and other conditions do not respond to existing treatments.
We owe it to our warfighters and veterans to turn over every stone
to alleviate the emotional and mental health blowback from their deployments.
It's disturbing to me and to the President
that hundreds, in fact thousands, of veterans are having to travel to Mexico
or other countries to experiment with interventions that hold great promise
but for which our knowledge is still insufficient.
This executive order will remove the legal impediments
that block American researchers, scientists, physicians, and clinicians
from properly studying these medicines
and, where appropriate, establishing protocols for their safe therapeutic use.
We're directing the FDA to prioritize therapies that have received
breakthrough therapy designation, treatments that early evidence suggests
may improve what we have today.
We're expanding the use of Right to Try
so that eligible patients with treatment-resistant conditions
can access these therapies under medical supervision.
We're also coordinating with the DEA and the Department of Justice
to begin rescheduling reviews after successful Phase III trials.
When the FDA determines a therapy is safe and effective,
patients should not face avoidable delays in access.
At the same time, HHS will work with states,
the Department of Veterans Affairs, and other federal partners
to strengthen research and share clinical data.
We will use that data to support faster, evidence-based decisions.
Through ARPA-H, HHS will allocate, as the President says,
at least $50 million from existing funds
to partner with states that are advancing these therapies.
We will support those efforts with funding,
with technical assistance and data sharing consistent with applicable law.
Researchers at Johns Hopkins, Stanford, and Harvard
and other leading institutions have reported meaningful
and, in some cases, extraordinary clinical improvements.
If these results continue, these therapies could offer longer-lasting relief,
not just symptom management,
and reduce economic burden of mental illness,
which costs this country hundreds of billions of dollars every year.
This policy creates a strict, science-based pathway for FDA approval
and controlled medical use.
The bottom line is progress in mental health treatment
has not matched the scale of the problem.
I want to thank Joe Rogan for helping bring national attention
to innovative, potentially life-saving treatments for veterans
and others living with mental illness
and for pushing this conversation into the mainstream.
I also want to thank Representative Morgan Luttrell from Texas
and former Navy SEAL Marcus Luttrell for their leadership on this issue.
I also want to thank the CEO of American Thrive again, Brian Hubbard,
and the organization's ambassador, former Navy SEAL Henry Berkowitz,
and former SEAL Team 6 Rob O'Neill.
I want to thank a couple of people for getting this record time across the finish line,
Callie Means and Dr. Heidi Overton.
Thank you, Heidi, for your leadership and for your attention to detail,
which is often frustrating.
I'm always right, so thank you.
And thank you, Mr. President.
Thank you very much, Bobby. You're fantastic.
Bobby's really done an amazing job.
You know, MAHA, it's a big deal.
And I want to thank you.
You work so hard, Oz and everybody up here.
And I just want to thank you. Great job.
And he's somewhat outside of the box, would you say?
And we need outside of the box a little bit, right?
Would you say, Oz?
Marty, please.
Great. Thank you, Mr. President.
Next week, the FDA will issue three national priority vouchers for serotonin 2A agonists,
also known as psychedelics.
Under this new program, in this administration, drugs can get approved in weeks,
not a year or a year plus, but in weeks,
if they are in line with our national priorities.
We have 18 vouchers in the program.
We'll be adding three more next week.
This is an unmet public health need, and there are potentially promising treatments.
That's why there's a sense of urgency around this.
That's why we're doing it now.
The applications are about to come in,
so this is the natural, perfect timing for this announcement.
For many men and women, they have been fighting battles on the ground.
But even after the wars are over, those battles continue in their mind.
Now, there are a lot of medications in medicine where we don't know exactly how it works,
but we see profound results.
If we actually listen to those who experience the therapeutic value,
we can learn as a medical field.
We just have to listen.
The stories of those individuals with dramatic results, that is data.
That is scientific data, even from a single individual.
We also have randomized control trials, and we have to do that,
because we need to be able to say there's good support when we recommend these therapeutics.
If you look at those trials, there's a 30% to 40% remission rate for conditions like PTSD.
Otherwise, we get nothing.
We have almost nothing for these conditions.
Today, the FDA is also announcing the first Ibogaine investigational new drug clearance.
This will pave the way for the first-ever human trials in the United States.
To be clear, the FDA will also have criteria and circumstances that have to be used to administer these drugs.
These drugs can have side effects, and so it's not like you go to the pharmacy and pick it up.
It's like medications that are administered in an ICU or an operating room.
There are criteria for doing it in a controlled setting.
Finally, given the urgency of today's mental health crisis, I just want to thank you, Mr. President,
and say the FDA is proud to support this broader effort to evaluate new therapeutics
for some of the greatest Americans we have in this country.
Thank you very much. You've done a great job, too. Appreciate it.
Marcus?
Yes, sir. To start off, Mr. President, thank you so much for having us in here and doing this.
You're going to save a lot of lives with it.
I'd like to say how grateful I am to have had the opportunity to go through the program and receive the Ibogaine.
It absolutely changed my life for the better.
I went through a lot of the programs that the veterans are going through,
and I always kind of felt like I was a victim coming out of the program.
When I came out of this, I felt like I had gotten my life back.
That was five years ago. I literally lived the best days of my life every single day.
I'm so thankful for everybody who's in this room to help out with this.
I know this is kind of a new frontier for us,
and just the fact that we're taking this kind of slow as smooth as fast,
and we're getting it in there so we can test this out so we don't get ahead of ourselves,
I think that's very impactful.
I think there's a lot of people out there that need help, not only our veterans,
but our civilian population that can benefit from this,
and it's going to do great things for our country to get it back on track
and open up a lot of doorways and pathways for us to be successful in the future.
Thank you for your time.
That's fantastic. So you've done this five years?
Yes, sir.
And it's just been a whole different day?
Every single day is a better day for me.
Wow. That's amazing, really.
I can vouch for that.
I mean, look at this guy. He's got guts. Come here.
Come on, guys.
Two good guys. I didn't realize you were involved in it already.
It's the best test service you can have. There's nothing better than that.
A man who's really respected by everybody, and he's a fantastic person,
Joe Rogan, to say a few words for this show.
I want to say that I'm here because of the men to my left.
Brian Hubbard and former Texas Governor Rick Perry came on my podcast.
They told me how impactful this medicine is,
and having that conversation with them,
millions of people got a chance to hear their story,
hear the stories of all the different people that have had life-changing experiences from it,
and I want Brian to be able to speak about this.
Brian, please.
Thank you, sir.
I heard that show. You have no trouble speaking.
He's had no trouble speaking.
I want to assure you that my presence here is the most concrete affirmation
that God has a wonderful sense of humor.
Thank you. Thank you.
Federal prohibition of psychedelic medicine in America is over.
On the 250th year of our nation's founding,
everyone who has fought for this day through decades of monumental struggle,
sacrifice, and suffering can now declare a seminal victory
for life, liberty, and the pursuit of happiness,
rights we bear as images of our eternal creator,
whose essence is almighty, eternal, unconditional love for each and every one of us.
This is the end of the beginning.
We have moved mountains, yet there are mountains to move.
Government systems which have relentlessly suppressed psychedelics
are the same systems which will now manage their emergence.
We dare not let our guard down for one second
and be hard-trigger ready to impose accountability
for incompetence, obstruction, or failure.
Credit belongs where credit is due.
With this executive order, President Trump has delivered
an epic victory for all humanity.
I thank him for having the courage to make this happen
and my mission brother, Joe Rogan, for having the spine to make the ask.
To our brothers and sisters in Gabon,
you have our deepest gratitude for your stewardship
of the sacred tree grown for the healing of nations.
I will do my best to deliver the respect and honor
you deserve for helping heal this nation.
It is my joy to deliver these good titans unto the meek,
which will hopefully bind up the brokenhearted,
proclaim liberty to the captives,
and the opening of the prison to all who are bound.
God bless you, and God bless America.
Thank you, brother.
Funny how this happened.
I sent President Trump some information.
We have a gigantic opiate problem in this country, obviously.
In 2024, more than 80,000 people died of overdoses.
It's a horrible number.
There's more than 5 million people that are addicted to opiates right now in this country.
With one dose of Ibogaine, more than 80% of people are free of that addiction.
With two doses, it's more than 90%.
I sent him that information.
The text message that came back, sounds great.
Do you want FDA approval? Let's do it.
It was literally that quick.
These drugs are illegal not because they're harmful.
They're illegal because of the 1970 Controlled Substances Act
that was passed by the Richard Nixon administration.
They did it to target the civil rights movement and the anti-war movement.
It's not because these drugs harm people.
For 56 years, we've lived under those terrible conditions.
We're free of that now.
Thanks to all these people that you see next to me,
and thanks to President Trump.
We all respect Joe.
He's a little bit more liberal.
That's okay.
I have a lot of friends that are liberal.
But Joe is an amazing guy.
He wrote me a little note about this, and I had it checked out.
I didn't just do it. I had it checked out.
I went to Bobby and Oz.
I went to some of the people that work for you.
Everybody came back with the same answer.
Normally, they'll come back, because this happens a lot.
I have a couple of them like that.
They're not sure. It goes two ways.
Everybody thought it was incredible.
I told Bobby, I said,
Bobby, let's just do it and get Oz involved.
It's going to get done so quickly.
You guys did a great job.
Would you like to say something, Oz?
Mr. President, I want to thank Matt Zorn, who's hiding in the back there,
who actually, on Sunday, wrote the draft for this.
You already thanked Heidi and Kelly,
but Susie Wiles makes everything run here.
This was an unimaginable task in one week
to be able to go from a series of connections
and communications with Joe Rogan through
the honey badger of them all, Bobby Kennedy,
who said, we're not going to stop.
We didn't start calling everyone down.
The Mike Step Spears has been involved,
and Chris Klump, who has been doing a fantastic job
helping run everything in great efficiency,
made something.
I just want to emphasize this.
This is an entire paradigm shift
away from a one-day-a-pill model,
which has failed so many.
And to the many who are drug-resistant
that Joe just spoke to,
this offers them a way of getting out of that rut.
The question now is, can we study
why it works to understand it better, to use it better?
That's what Jay Bhattacharya is going to do,
NIH, with major funding support, perhaps ARPA as well.
Marty spoke eloquently about
the FDA's accelerated pathway for this.
And then, when we learn more,
figure out better ways of getting access
to these products through our health care system.
This is an extraordinarily exciting day,
and it would never happen if the President
just would not take no for an answer.
He called on the way, Joe, to the fight on Saturday.
And I think he was as determined
to get this done
as the men in those rings
and women in those rings that night.
Thank you, sir.
I want to thank
Professor Nolan Williams.
When I was a professor at Stanford,
I got to know him,
and he taught me about Ibogaine
and all the promise that it has
for treatment-resistant depression
and so many other conditions.
And frankly, for me,
I learned a lot.
Unfortunately, he passed away last year.
I want to thank this amazing team
that just moved heaven and earth to get things done.
I do want to emphasize,
this is something that we're still studying,
and we have to keep studying.
We have to figure out the right way
to make sure we administer it,
that it's safe,
that we don't just take it for granted.
We already know everything, because we don't.
And for the NIH and for ARPA-H,
we are absolutely committed to making sure
that we keep studying it,
keep getting the best gold standard science on it.
You can see here,
Nora Volkow was my National Institute
of Drug Abuse director.
She's been an absolute hero
in just developing scientific...
So the commitment for American science
to focus on this,
and in many ways,
that scientific advance has brought us to this moment.
So thank you, President Trump.
But if it's good, we want to get it fully approved fast, right?
I mean, for the things that have great evidence,
and that's what they're...
Because, you know, these studies, they go on for a long time.
I mean, I have a witness right here.
These two incredible brothers.
That, to me, is a study, right?
Just as Commissioner McCary said,
there's stuff that we know,
and we can tell it works.
We still have to figure out sometimes
how it works or why it works.
That we've got to keep doing, even as we move forward fast.
But it does work.
Some of those, I mean, absolutely.
Some of those...
Yes, it works.
I'm trying to answer it,
because it either works or it doesn't.
I would think that there's been a lot of research already.
Indirect research.
Maybe the ultimate research, people that have taken it.
Because I've spoken to people
that have taken it, aside from
the trail, both of them.
I've spoken to
five people that...
Mr. President, it works.
I've done it three times, of course.
It fixed my demonic relationship...
This is Rob O'Neill.
He's a friend of mine and a great guy.
It fixed my demonic relationship with alcohol.
It saved my life, and then it saved my wife.
So, every day is a blessing.
It took about three years of...
I did it three times.
It's a different adventure every time.
That's not fun.
So, without it, you would have had problems?
I did it with...
There was a Green Beret 28-year sergeant major
that told me when we finished,
make sure you tell Amber Capone,
the CEO of Veterans Exploring Treatment Solutions,
that she saved my life, because I was going to kill myself
next week. This was my last chance.
A 28-year veteran told me that.
This works.
Mr. President,
could you ask Marcus
to speak about his experience?
Thank you, Secretary.
Mr. President,
what Rob O'Neill is talking about, my wife Amber Capone
is the CEO of our charity,
Veterans Exploring Treatment Solutions.
We had prayed for this day
to come 10 years ago when we started the charity.
We've been sending veterans outside the country,
Joe, that you've been talking about for years,
several thousand now, and we said
the mission will end once this day happens,
so we believe this is a huge step
in maybe that the mission goes away.
Now we have affordable access right here in the U.S.
Why didn't they get it done?
We're getting it done right now.
You're getting it done.
Why are the presidents looking at it?
Why didn't they get it done?
I think we needed you.
That's my job. I can answer that question, sir.
There's a small group of us
in the House
that have been trying to move legislation
since I showed up.
Mr. Correa, Mr. Bergman,
Mr. McCall, Mr. Crenshaw,
every year have tried to move legislation.
That side of the room is not going to like what I have to say about this.
And every year it has all
fallen short.
Every year it has all fallen short.
And it's because of the
proverbial roadblocks that are always in the way.
Fair assessment.
But those members of myself
were convicted never to give up.
Ever.
And with this executive order,
I'm going to maintain composure, Mr. President,
with this executive order, you have broken down
those barriers
and allowed us.
I have all the faith in the world
that this will codify and remain forever.
So thank you very much for taking care of your
service members and your veterans.
And giving the members that have been working on this for so long
a chance. Thank you, sir.
Well, this, when I sign this,
this does solve it for
the three-year, but we'll get that
codified very soon.
Once I sign it, we get them
codified, so that'll be,
we'll make it permanent. I have no doubt
it's going to be working.
Would anybody else like to say something?
These two women are so talented.
Well, I love
an executive order that says
research, research, research.
Because it's ultimately what guides us
on how to ultimately do things.
And I think that
this is what hopefully will
start to happen. And bringing up
change in a system that has been
very difficult to
modify because of
prior experiences.
These drugs have unique
characteristics that could actually,
if we don't investigate them,
can bring us into potential
applications that currently we're not thinking
about. But if we close the door
to science, if we close the door to data,
we'll just keep on doing the same
thing again and again.
Do you think the door was closed?
It was hard to do recently. Very, very hard.
And it's actually just by scheduling as
I want, it makes it very difficult.
So this is a big move then.
It will facilitate
bigger than just this one thing that we're talking about.
That's good. I'm glad we didn't
waste a Saturday morning.
Please.
Yes. Mr. President,
this is a much-needed
bold move for precision
mental health for our
veterans and others, and
accelerates access to
personalized, targeted treatments.
As you
have heard, many, many veterans
and others experiencing
mental health disorders, they
go through up to years
of trial and error,
trying one treatment that doesn't work,
trying another and not knowing why.
My work
at Stanford and with my
colleagues is to develop
brain-based tests
that can be measured right now
in our VA and other locations
that help us understand
why these new treatments work
and who they'll be most
effective for.
So with your mandate,
we are in a position to really
accelerate saving lives
of many more people and getting them well
sooner, and I believe
that with this, the
United States will be the first country
in the world to treat
mental health like
we do cancer and like
we do many other chronic mental
illnesses.
The world is actually
watching this because there are a lot of countries that
want to do this and
they haven't been able to. They're going to be following
suit very, very strongly.
Thank you very much both.
Anybody else? You guys okay?
Let's sign it, right?
Mr. President, thank you.
This treatment saved my life as well
and so many fellow veterans. It helped me get off
opiates, stop using a nerve stimulator
I hadn't planted, sleep for the first
time in over 10 years.
So thank you. And you have no doubt, right?
Zero.
To me, that's the best
research of all, frankly. Absolutely.
Okay, it's my honor.
That's a good one.
You think Biden can do that?
I think we'll keep it on the subject
pretty much. We'll have some questions
on Iran, I know that. But this is such
an important subject that
I'd rather let this just speak for
itself. And we'll be talking about
Iran later. We have very good
conversations going on.
It's working out very well.
They got a little cute, as they have been doing
for 47 years. Nobody ever took them
on. We took them on.
They have no Navy. They have no
Air Force. They have no leaders.
They have no nothing. Actually, their leaders are
it is regime change.
You call that enforced
regime change. But
we're talking to them. They
wanted to close up the
strait again, as they've been doing
for years.
They can't blackmail us.
In fact, a lot of the ships are coming up to Texas.
I don't know if you know. In Louisiana, the ships are
coming up. They got used to it.
Maybe they'll keep doing it. It's worked out
pretty good. But
it's going, actually, along
very well. And
we'll see. But we'll have some information
by the end of the day. We're talking to them.
And, you know, we're taking a
tough stand. They've killed a lot of people.
A lot of our people have been killed. A lot of your fellow
soldiers have been killed over
the years by Iran.
The roadside bomb.
Soleimani. I killed Soleimani.
Thank you for that. He was making the explosive form
penetrators. They're making them in Iran, bringing them to
Iraq and blasting through the vehicles.
He was the father of the roadside bomb,
essentially. And he killed a lot of people.
And when you see soldiers
or others, but soldiers generally walking
around with no legs, with no arms,
a face that's been smashed,
that was Soleimani, that was Iran that did
that. So we have a much
different view on it than other presidents.
They've gotten away with
murder for 47 years. They're not getting
away with it anymore. Does
anybody have any questions with the
great professionals? Please.
So I wanted to know, is this, could this
potentially ever be available from the VA?
You know, someone lives over here.
You guys have been down in Mexico
together. But it's really expensive.
And this is another drug that's expensive.
We have the right guy, Oz.
A lot of Americans need this.
Where are you going with this question?
He's talking about expense and availability.
So I spoke to Doug Collins.
Obviously, both he, and he obviously
pays for the VA, and we pay for Medicare, Medicaid,
children's health insurance, are
very focused on the results that the NIH
and FDA are going to offer us.
We have a mechanism of creating
models, CMMI.
That might be the wise way to go, because
we can continue to study the impact.
This is such a massive shift in how you deliver care.
Imagine, instead of taking
a pill a day for your depression,
you go through one treatment, but you have to have people
watching you. It's a very different world.
So we're working that through. That's why the president
who, I think this is the perfect step
to get everything rolling, to deliver on the promise
he made to them. What timing would you say on that,
before you know? Well, we could have
a CMMI model that we would announce
by the end of this year. But the reason I'm not
committing to that now is I
want to make sure that the FDA and NIH have
time, along with the great scientists, to give us
a bit more information about how to deliver care.
I'll give you one concrete example.
For things like, well, Ibogaine is a little different
story, but you wouldn't want two people in the room during
the treatment. That's true for many of these
approaches. That's a very different way of
delivering medicine. And so the
models that Abe Sutton runs
that group for us, and he's done a great job for the
president, that would be probably the fastest way
of moving forward, and give the VA data
so they can make wiser decisions,
because Doug Collins is very focused on this.
There's one thing I'd add. There's nothing
more expensive right now than the
mental health crisis in America.
21% of Americans have a
diagnosable mental health condition.
The leading cause,
excuse me, the second leading cause of
death for young adults today
is suicide.
Mr. President, antidepressants
right now are the most prescribed
class medications in the country.
Over 20% of women are on an
antidepressant. And is that good in terms of
do they work? There's highly problematic
research
on the fact that over 20% of
U.S. women are on
these drugs that are prescribed for
life. We have a mental health
crisis. Do they work?
No.
You know, I'm on a couple of them
and...
We'll get you down in there.
Mr. President, what you
and Secretary Kennedy unlocked
is, for the first time,
questioning this system
where we spend three
times more per capita than any
other country in the world, and we are
living six, seven years less.
We have the highest rates of suicide and
depression in the developed world.
The incentives of our system...
And by the way, autism, which we're really working hard on.
Right, Bob?
And we're coming up with some pretty amazing findings.
Pediatric cancer. It's the highest rates in the world.
We are
struggling and we're paying more than any other country,
and the power of this executive order is
really representative and gives
validation to the cries of Maha Moms
and the votes of Maha Moms, because
for the first time, it's taking a therapy
that's one time. This is a one time.
Not a lifetime drug
that can change someone's life, and that's the power,
and I think that's why the system is developed.
So the antidepressants, although we read about it
and we prescribe to our military,
they're not very effective?
It's a lifetime drug, and...
Well, even if it's lifetime, but do they...
Look at what's happened as we've prescribed them
and made them one of the most prescribed classes of medication.
The numbers are not great.
Perhaps I could jump in from the
scientific side.
What's the timeline for this?
I think what's really
important about your order is
you include, we really want to
understand why these rapid
acting treatments work.
We need that for every treatment
in mental health illnesses.
Standard antidepressants
in research, they do work for some
people, but certainly not everyone.
And if we think of
cancer, all other conditions,
we have a test to know
which treatment is needed.
And we don't have that
for mental illness. It's guesswork.
With that, it either works
or it doesn't work, and you have the results.
So as part of this order,
I think it's really important
that we're able
to have the investment to
understand who does this work for
and the test to
accompany that.
Do you think this could be a big step
above antidepressants?
What we're doing?
I think it can be identifying who doesn't
respond to an antidepressant straight away
rather than waiting for years.
What percentage of people
respond positively
to antidepressants?
20 to 30 percent.
That's not great.
Thank you very much.
Mr. President, what's the timeline for those
with mental health disorders, substance abuse
disorders, to readily
take advantage of this treatment based upon
the executive order that you're signing today?
I'd like to ask maybe Marty that question.
Sure. First of all,
right now it's available on clinical trials.
We have not had applications in-house
at the FDA. There was one that came in
under the Biden administration. It was kicked
out and not accepted.
We now have three applications that
are imminent, and we'll be issuing
vouchers next week. The fastest
FDA approval was 42
days during the HIV epidemic.
On our national priority
voucher program under President Trump,
we are now down to that timeframe
on a routine basis
instead of a year. In my
opinion, we need the same level
of urgency we had with HIV
for PTSD and depression
and anxiety and our mental health
disorder and cancer and heart disease
and so many other conditions. So you're going to
see decisions out from the FDA
later this summer, as soon as we get the applications.
Mr. President,
I really like that answer.
Thank you, Mr. President.
In regards to the timing of the executive
order, was there not enough known
about this treatment a year
ago or five years ago
or eight years ago to sign the
executive order that you signed?
You want to answer that question? Go ahead.
In 2016, the
lead professor at Johns Hopkins
said this was the most promising
therapy that he's
seen in his career and many doctors
from leading institutions said that.
There's been a hold, there's been
incentives against this and the
bravery and leadership of President Trump.
So you mean artificial barriers?
To be clear, it's starting a
fast track scientific process
that's subject to FDA approval.
This has been known
among leading institutions many times
as a very promising therapy.
Could it not have been signed in your
first term or there just wasn't enough information?
Nobody told me about it, frankly.
All of a sudden, I've been getting
a lot of calls. In all fairness,
I think a lot's been learned over the last
few years. A lot has
been learned over the past few years.
In the first term, if I was
standing behind the President, I would have been much more
comfortable than I am now, thanks to the research
that's been done. There's still a lot
more to do. It's worked for so many
people. It's really a great move
to do this, but the research is
really important because we're going to keep improving,
keep learning, and make sure
that the people get the treatment they need
when they are depressed, when they are addicted,
when they have PTSD.
If you keep doing the research and
also acknowledge the research that's been
done, that's when you get good health policy.
And Secretary Kennedy's role,
he just doesn't stop.
Every day, all day long
until he gets these things done. This is not an easy
boulder to push up the hill.
Secretary Kennedy
was undaunted, and he'd been talking about it
for a while, so he had a passion anyway,
but his mentoring has allowed a lot of
folks to move this quickly.
If I can jump
in rapidly, because I was one
of those doctors that was not supportive
of psychedelic therapy because
I thought it was magical thinking,
but over the past
six to ten years, we have seen
an emergence of data that
we cannot ignore. These drugs
have the capacity, as was mentioned before,
with one single administration
to change the behavior
of someone towards a
therapeutic effect. In animal
models, one single administration
recreates
pathways that have been eroded
because of pathology.
We have a tool that potentially
could allow us to
basically manipulate
the ability of our own bodies
to heal itself if we know
how to properly use it. And that's why
research, as I mentioned before,
is opening up doors
to explore what else can we do,
how to optimally use it.
But you're just hearing and seeing
automatic research. You're hearing
and seeing things now
that you wouldn't have really,
you wouldn't be able to have
done a couple of years ago. I mean,
it just seems to me, I've been hearing about it
a little bit over the last year.
Over the last year. I never heard
anything about it in the past.
It was almost like taboo.
It's not taboo anymore.
And there was nothing of science
neither. And I think that's where the evidence
speaks for itself. And ultimately,
that's what I say, I was one of those
doctors that didn't believe in it. So,
we do data in order to
change our perspective and to do things
better. I was surprised to hear about
the antidepressants. I assumed they'd be
better. That's not very good. So, Bobby,
you're going to push it very hard? Yes.
You're going to do it?
These two guys
and this third with Rob
too and with you.
I mean, that to me is research, right?
Maybe the ultimate research, right? Big fans.
All big fans.
Well, I want to thank everybody and
it's going to be...
applause
